Immuneering Corporation
IPOImmuneering | Deep Cyclic Inhibitors for MAPK-Driven Cancers
Public · Cambridge, United States · Founded 2008 · $25.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Website
- immuneering.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Private EquityAug 2025
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage oncology company developing Deep Cyclic Inhibitors — a new class of cancer therapies targeting MAPK-driven cancers.
Summary
Immuneering Corporation is a Biotech company based in Cambridge, United States, founded in 2008. It has raised $25.0M in total across 1 round, most recently a $25.0M Private Equity round in Aug 2025. Investors include Oppenheimer Holdings, SVB Leerink and Sanofi Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Sep 2025
Sign up to see all 2 events
Funding: Private Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immuneering-corporation"><img src="https://indexed.vc/api/badge/company/immuneering-corporation" alt="Immuneering Corporation on Indexed.vc" width="260" height="76" /></a>